SCA Pharmaceuticals
8821 Knoedl Court
Little Rock
Arkansas
72205
United States
About SCA Pharmaceuticals
7 articles about SCA Pharmaceuticals
-
SCA Pharma Names Hugh O'Neill as Chief Commercial Officer
3/9/2023
SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced the addition of Hugh O'Neill as Chief Commercial Officer.
-
SCA Pharma Awarded Multi-Year Contract with Vizient, Supporting Better Drug Accessibility
11/1/2022
SCA Pharma, a nationally recognized leader in the 503B compounded pharmaceuticals outsourcing industry, providing quality, service, and value to hospitals nationwide, has announced that Vizient has awarded a multi-year agreement to the company for its full range of 503B ready-to-use products.
-
SCA Pharma Names Louis Pace as Chief Financial Officer and Chief Information Officer
7/14/2022
SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced the addition of Louis Pace as Chief Financial Officer and Chief Information Officer.
-
The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals
1/21/2021
SCA Pharmaceuticals, LLC, has entered into a definitive membership interest purchase agreement with The Vistria Group and Excellere Partners.
-
SCA Pharma Adds Medication Intelligence to All Products with Kit Check’s Embedded RFID Tag
9/9/2020
Kit Check™, the leader in automated and intelligent medication management solutions, today announced that it has signed an agreement with SCA Pharma that allows SCA to add an embedded RFID tag to all of its products. SCA Pharma, an FDA registered 503B entity, will be the first 503B partner to utilize Kit Check’
-
SCA Pharmaceuticals Appoints Milton Boyer As Chief Executive Officer
9/15/2017
-
SCA Pharmaceuticals Announces The Retirement Of Dr. Gene Graves, Founder And Chief Executive Officer
9/6/2017